0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PD-1/PD-L1 Inhibitors for Weight Loss Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-30Z12665
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global PD 1 PD L1 Inhibitors for Weight Loss Market Research Report 2023
BUY CHAPTERS

Global PD-1/PD-L1 Inhibitors for Weight Loss Market Research Report 2025

Code: QYRE-Auto-30Z12665
Report
May 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

PD-1/PD-L1 Inhibitors for Weight Loss Market Size

Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe.

PD-1/PD-L1 Inhibitors for Weight Loss Market

PD-1/PD-L1 Inhibitors for Weight Loss Market

The global market for PD-1/PD-L1 Inhibitors for Weight Loss was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to our Wellness & Health Research Center, the global wellness & health economy was valued at US dollars 4.8 trillion. Asia Pacific was the region with the highest spending on big health in 2022, with a total spending of $1.68 trillion, followed by North America ($1.42 trillion) and Europe ($1.0 trillion). According to the health industry accounting analysis data disclosed by the Health Development Research Center of the National Health Commission, from 2019 to 2021, the market size of the health service industry grew by an average of 7.0% per year, and the specific data increased from 7.7 trillion yuan to 8.8 trillion yuan. China"s health industry revenue reached 8.0 trillion yuan in 2021, with an increase of 8.1%. According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. And China and the United States accounted for 44% of total sports spending.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PD-1/PD-L1 Inhibitors for Weight Loss, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-1/PD-L1 Inhibitors for Weight Loss.
The PD-1/PD-L1 Inhibitors for Weight Loss market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PD-1/PD-L1 Inhibitors for Weight Loss market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-1/PD-L1 Inhibitors for Weight Loss manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PD-1/PD-L1 Inhibitors for Weight Loss Market Report

Report Metric Details
Report Name PD-1/PD-L1 Inhibitors for Weight Loss Market
Accounted market size in 2022 750 billion
Base Year 2022
Segment by Type
  • PD-1 Inhibitors
  • PD-L1 Inhibitors
Segment by Application
  • Woman
  • Man
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine, Junshi Biosciences, Merck KGaA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of PD-1/PD-L1 Inhibitors for Weight Loss manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of PD-1/PD-L1 Inhibitors for Weight Loss in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the PD-1/PD-L1 Inhibitors for Weight Loss Market share by region?

Ans: And China and the United States accounted for 44% of total sports spending.

Who are the main players in the PD-1/PD-L1 Inhibitors for Weight Loss Market report?

Ans: The main players in the PD-1/PD-L1 Inhibitors for Weight Loss Market are Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical, Regeneron, Innovent, Hengrui Medicine, Junshi Biosciences, Merck KGaA

What are the Application segmentation covered in the PD-1/PD-L1 Inhibitors for Weight Loss Market report?

Ans: The Applications covered in the PD-1/PD-L1 Inhibitors for Weight Loss Market report are Woman, Man

What are the Type segmentation covered in the PD-1/PD-L1 Inhibitors for Weight Loss Market report?

Ans: The Types covered in the PD-1/PD-L1 Inhibitors for Weight Loss Market report are PD-1 Inhibitors, PD-L1 Inhibitors

Recommended Reports

Weight Loss Products

Medical Devices Bariatrics

PD-1/PD-L1 Related

1 PD-1/PD-L1 Inhibitors for Weight Loss Market Overview
1.1 Product Definition
1.2 PD-1/PD-L1 Inhibitors for Weight Loss by Type
1.2.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Value Comparison by Type (2024 VS 2031)
1.2.2 PD-1 Inhibitors
1.2.3 PD-L1 Inhibitors
1.3 PD-1/PD-L1 Inhibitors for Weight Loss by Application
1.3.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Value by Application (2024 VS 2031)
1.3.2 Woman
1.3.3 Man
1.4 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size Estimates and Forecasts
1.4.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue 2020-2031
1.4.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales 2020-2031
1.4.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 PD-1/PD-L1 Inhibitors for Weight Loss Market Competition by Manufacturers
2.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Manufacturers (2020-2025)
2.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Manufacturers (2020-2025)
2.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of PD-1/PD-L1 Inhibitors for Weight Loss, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of PD-1/PD-L1 Inhibitors for Weight Loss, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PD-1/PD-L1 Inhibitors for Weight Loss, Product Type & Application
2.7 Global Key Manufacturers of PD-1/PD-L1 Inhibitors for Weight Loss, Date of Enter into This Industry
2.8 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Competitive Situation and Trends
2.8.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Concentration Rate
2.8.2 The Global 5 and 10 Largest PD-1/PD-L1 Inhibitors for Weight Loss Players Market Share by Revenue
2.8.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Scenario by Region
3.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Region: 2020-2031
3.2.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Region: 2020-2025
3.2.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Region: 2026-2031
3.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Region: 2020-2031
3.3.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Region: 2020-2025
3.3.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Region: 2026-2031
3.4 North America PD-1/PD-L1 Inhibitors for Weight Loss Market Facts & Figures by Country
3.4.1 North America PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2020-2031)
3.4.3 North America PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Facts & Figures by Country
3.5.1 Europe PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2020-2031)
3.5.3 Europe PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Market Facts & Figures by Region
3.6.1 Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Sales by Region (2020-2031)
3.6.3 Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America PD-1/PD-L1 Inhibitors for Weight Loss Market Facts & Figures by Country
3.7.1 Latin America PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2020-2031)
3.7.3 Latin America PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Market Facts & Figures by Country
3.8.1 Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2020-2031)
3.8.3 Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Type (2020-2031)
4.1.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Type (2020-2025)
4.1.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Type (2026-2031)
4.1.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Type (2020-2031)
4.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Type (2020-2031)
4.2.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Type (2020-2025)
4.2.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Type (2026-2031)
4.2.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Type (2020-2031)
4.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Price by Type (2020-2031)
5 Segment by Application
5.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Application (2020-2031)
5.1.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Application (2020-2025)
5.1.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Application (2026-2031)
5.1.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Application (2020-2031)
5.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Application (2020-2031)
5.2.1 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Application (2020-2025)
5.2.2 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Application (2026-2031)
5.2.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Application (2020-2031)
5.3 Global PD-1/PD-L1 Inhibitors for Weight Loss Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Company Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Company Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Ono Pharmaceutical
6.5.1 Ono Pharmaceutical Company Information
6.5.2 Ono Pharmaceutical Description and Business Overview
6.5.3 Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.5.5 Ono Pharmaceutical Recent Developments/Updates
6.6 Regeneron
6.6.1 Regeneron Company Information
6.6.2 Regeneron Description and Business Overview
6.6.3 Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.6.5 Regeneron Recent Developments/Updates
6.7 Innovent
6.7.1 Innovent Company Information
6.7.2 Innovent Description and Business Overview
6.7.3 Innovent PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Innovent PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.7.5 Innovent Recent Developments/Updates
6.8 Hengrui Medicine
6.8.1 Hengrui Medicine Company Information
6.8.2 Hengrui Medicine Description and Business Overview
6.8.3 Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.8.5 Hengrui Medicine Recent Developments/Updates
6.9 Junshi Biosciences
6.9.1 Junshi Biosciences Company Information
6.9.2 Junshi Biosciences Description and Business Overview
6.9.3 Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.9.5 Junshi Biosciences Recent Developments/Updates
6.10 Merck KGaA
6.10.1 Merck KGaA Company Information
6.10.2 Merck KGaA Description and Business Overview
6.10.3 Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Product Portfolio
6.10.5 Merck KGaA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PD-1/PD-L1 Inhibitors for Weight Loss Industry Chain Analysis
7.2 PD-1/PD-L1 Inhibitors for Weight Loss Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PD-1/PD-L1 Inhibitors for Weight Loss Production Mode & Process Analysis
7.4 PD-1/PD-L1 Inhibitors for Weight Loss Sales and Marketing
7.4.1 PD-1/PD-L1 Inhibitors for Weight Loss Sales Channels
7.4.2 PD-1/PD-L1 Inhibitors for Weight Loss Distributors
7.5 PD-1/PD-L1 Inhibitors for Weight Loss Customer Analysis
8 PD-1/PD-L1 Inhibitors for Weight Loss Market Dynamics
8.1 PD-1/PD-L1 Inhibitors for Weight Loss Industry Trends
8.2 PD-1/PD-L1 Inhibitors for Weight Loss Market Drivers
8.3 PD-1/PD-L1 Inhibitors for Weight Loss Market Challenges
8.4 PD-1/PD-L1 Inhibitors for Weight Loss Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Competitive Situation by Manufacturers in 2024
 Table 4. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg) of Key Manufacturers (2020-2025)
 Table 5. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market PD-1/PD-L1 Inhibitors for Weight Loss Average Price (US$/Mg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of PD-1/PD-L1 Inhibitors for Weight Loss, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of PD-1/PD-L1 Inhibitors for Weight Loss, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of PD-1/PD-L1 Inhibitors for Weight Loss, Product Type & Application
 Table 12. Global Key Manufacturers of PD-1/PD-L1 Inhibitors for Weight Loss, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global PD-1/PD-L1 Inhibitors for Weight Loss by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1/PD-L1 Inhibitors for Weight Loss as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Region (2020-2025) & (Kg)
 Table 18. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Region (2020-2025)
 Table 19. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales by Region (2026-2031) & (Kg)
 Table 20. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Region (2026-2031)
 Table 21. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Region (2020-2025)
 Table 23. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Region (2026-2031)
 Table 25. North America PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2020-2025) & (Kg)
 Table 27. North America PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2026-2031) & (Kg)
 Table 28. North America PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2020-2025) & (Kg)
 Table 32. Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2026-2031) & (Kg)
 Table 33. Europe PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Sales by Region (2020-2025) & (Kg)
 Table 37. Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Sales by Region (2026-2031) & (Kg)
 Table 38. Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2020-2025) & (Kg)
 Table 42. Latin America PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2026-2031) & (Kg)
 Table 43. Latin America PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2020-2025) & (Kg)
 Table 47. Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales by Country (2026-2031) & (Kg)
 Table 48. Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg) by Type (2020-2025)
 Table 51. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg) by Type (2026-2031)
 Table 52. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Type (2020-2025)
 Table 53. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Type (2026-2031)
 Table 54. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Type (2020-2025)
 Table 57. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Type (2026-2031)
 Table 58. Global PD-1/PD-L1 Inhibitors for Weight Loss Price (US$/Mg) by Type (2020-2025)
 Table 59. Global PD-1/PD-L1 Inhibitors for Weight Loss Price (US$/Mg) by Type (2026-2031)
 Table 60. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg) by Application (2020-2025)
 Table 61. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg) by Application (2026-2031)
 Table 62. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Application (2020-2025)
 Table 63. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Application (2026-2031)
 Table 64. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Application (2020-2025)
 Table 67. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Application (2026-2031)
 Table 68. Global PD-1/PD-L1 Inhibitors for Weight Loss Price (US$/Mg) by Application (2020-2025)
 Table 69. Global PD-1/PD-L1 Inhibitors for Weight Loss Price (US$/Mg) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 73. Merck PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Bristol-Myers Squibb Company Information
 Table 76. Bristol-Myers Squibb Description and Business Overview
 Table 77. Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 78. Bristol-Myers Squibb PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 79. Bristol-Myers Squibb Recent Developments/Updates
 Table 80. Roche Company Information
 Table 81. Roche Description and Business Overview
 Table 82. Roche PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 83. Roche PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 84. Roche Recent Developments/Updates
 Table 85. AstraZeneca Company Information
 Table 86. AstraZeneca Description and Business Overview
 Table 87. AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 88. AstraZeneca PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 89. AstraZeneca Recent Developments/Updates
 Table 90. Ono Pharmaceutical Company Information
 Table 91. Ono Pharmaceutical Description and Business Overview
 Table 92. Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 93. Ono Pharmaceutical PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 94. Ono Pharmaceutical Recent Developments/Updates
 Table 95. Regeneron Company Information
 Table 96. Regeneron Description and Business Overview
 Table 97. Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 98. Regeneron PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 99. Regeneron Recent Developments/Updates
 Table 100. Innovent Company Information
 Table 101. Innovent Description and Business Overview
 Table 102. Innovent PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 103. Innovent PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 104. Innovent Recent Developments/Updates
 Table 105. Hengrui Medicine Company Information
 Table 106. Hengrui Medicine Description and Business Overview
 Table 107. Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 108. Hengrui Medicine PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 109. Hengrui Medicine Recent Developments/Updates
 Table 110. Junshi Biosciences Company Information
 Table 111. Junshi Biosciences Description and Business Overview
 Table 112. Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 113. Junshi Biosciences PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 114. Junshi Biosciences Recent Developments/Updates
 Table 115. Merck KGaA Company Information
 Table 116. Merck KGaA Description and Business Overview
 Table 117. Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
 Table 118. Merck KGaA PD-1/PD-L1 Inhibitors for Weight Loss Product
 Table 119. Merck KGaA Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. PD-1/PD-L1 Inhibitors for Weight Loss Distributors List
 Table 123. PD-1/PD-L1 Inhibitors for Weight Loss Customers List
 Table 124. PD-1/PD-L1 Inhibitors for Weight Loss Market Trends
 Table 125. PD-1/PD-L1 Inhibitors for Weight Loss Market Drivers
 Table 126. PD-1/PD-L1 Inhibitors for Weight Loss Market Challenges
 Table 127. PD-1/PD-L1 Inhibitors for Weight Loss Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of PD-1/PD-L1 Inhibitors for Weight Loss
 Figure 2. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Share by Type: 2024 & 2031
 Figure 4. PD-1 Inhibitors Product Picture
 Figure 5. PD-L1 Inhibitors Product Picture
 Figure 6. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Share by Application: 2024 & 2031
 Figure 8. Woman
 Figure 9. Man
 Figure 10. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size (2020-2031) & (US$ Million)
 Figure 12. Global PD-1/PD-L1 Inhibitors for Weight Loss Sales (2020-2031) & (Kg)
 Figure 13. Global PD-1/PD-L1 Inhibitors for Weight Loss Average Price (US$/Mg) & (2020-2031)
 Figure 14. PD-1/PD-L1 Inhibitors for Weight Loss Report Years Considered
 Figure 15. PD-1/PD-L1 Inhibitors for Weight Loss Sales Share by Manufacturers in 2024
 Figure 16. Global PD-1/PD-L1 Inhibitors for Weight Loss Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest PD-1/PD-L1 Inhibitors for Weight Loss Players: Market Share by Revenue in PD-1/PD-L1 Inhibitors for Weight Loss in 2024
 Figure 18. PD-1/PD-L1 Inhibitors for Weight Loss Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global PD-1/PD-L1 Inhibitors for Weight Loss Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Country (2020-2031)
 Figure 21. North America PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Country (2020-2031)
 Figure 22. United States PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Country (2020-2031)
 Figure 25. Europe PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Country (2020-2031)
 Figure 26. Germany PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Region (2020-2031)
 Figure 33. China PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Country (2020-2031)
 Figure 41. Latin America PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Colombia PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa PD-1/PD-L1 Inhibitors for Weight Loss Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE PD-1/PD-L1 Inhibitors for Weight Loss Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of PD-1/PD-L1 Inhibitors for Weight Loss by Type (2020-2031)
 Figure 52. Global Revenue Market Share of PD-1/PD-L1 Inhibitors for Weight Loss by Type (2020-2031)
 Figure 53. Global PD-1/PD-L1 Inhibitors for Weight Loss Price (US$/Mg) by Type (2020-2031)
 Figure 54. Global Sales Market Share of PD-1/PD-L1 Inhibitors for Weight Loss by Application (2020-2031)
 Figure 55. Global Revenue Market Share of PD-1/PD-L1 Inhibitors for Weight Loss by Application (2020-2031)
 Figure 56. Global PD-1/PD-L1 Inhibitors for Weight Loss Price (US$/Mg) by Application (2020-2031)
 Figure 57. PD-1/PD-L1 Inhibitors for Weight Loss Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS